Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy

Jaclyn H. Chu, Stephen J. Gange, Kathryn Anastos, Howard Minkoff, Helen Cejtin, Melanie Bacon, Alexandra Levine, Ruth M. Greenblatt

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The role of hormonal contraceptive use in the effectiveness of highly active antiretroviral therapy (HAART) was examined among participants in the Women's Interagency HIV Study who were followed from HAART initiation to 2001. Propensity score selection was used to match 77 hormonal contraceptive users with 77 nonusers on age, race, and pre-HAART CD4-positive T-lymphocyte (CD4+ cell) count and viral load. The authors compared hormonal contraceptive users and nonusers with regard to the CD4+ cell count and viral load responses to HAART upon initiation. Proportional hazards analyses were used to assess the effect of hormonal contraceptive use on times to increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 and achievement of an undetectable viral load. There were no statistically significant differences in CD4+ cell counts and log viral load responses by hormone use after HAART initiation, except in log viral load at the third visit after initiation (p = 0.047). Time-dependent hormonal contraceptive use was not a statistically significant predictor of achieving increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 or an undetectable viral load (p = 0.517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART.

Original languageEnglish (US)
Pages (from-to)881-890
Number of pages10
JournalAmerican Journal of Epidemiology
Volume161
Issue number9
DOIs
StatePublished - May 1 2005

Fingerprint

Highly Active Antiretroviral Therapy
Contraceptive Agents
Viral Load
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes
Propensity Score
HIV
Hormones

Keywords

  • Antiretroviral therapy, highly active
  • Contraceptives, oral, hormonal
  • HIV
  • Hormones
  • Levonorgestrel
  • Medroxyprogesterone 17-acetate

ASJC Scopus subject areas

  • Epidemiology

Cite this

Chu, J. H., Gange, S. J., Anastos, K., Minkoff, H., Cejtin, H., Bacon, M., ... Greenblatt, R. M. (2005). Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. American Journal of Epidemiology, 161(9), 881-890. https://doi.org/10.1093/aje/kwi116

Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. / Chu, Jaclyn H.; Gange, Stephen J.; Anastos, Kathryn; Minkoff, Howard; Cejtin, Helen; Bacon, Melanie; Levine, Alexandra; Greenblatt, Ruth M.

In: American Journal of Epidemiology, Vol. 161, No. 9, 01.05.2005, p. 881-890.

Research output: Contribution to journalArticle

Chu, JH, Gange, SJ, Anastos, K, Minkoff, H, Cejtin, H, Bacon, M, Levine, A & Greenblatt, RM 2005, 'Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy', American Journal of Epidemiology, vol. 161, no. 9, pp. 881-890. https://doi.org/10.1093/aje/kwi116
Chu, Jaclyn H. ; Gange, Stephen J. ; Anastos, Kathryn ; Minkoff, Howard ; Cejtin, Helen ; Bacon, Melanie ; Levine, Alexandra ; Greenblatt, Ruth M. / Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. In: American Journal of Epidemiology. 2005 ; Vol. 161, No. 9. pp. 881-890.
@article{95507a2c0f164226bf5e393d73dab049,
title = "Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy",
abstract = "The role of hormonal contraceptive use in the effectiveness of highly active antiretroviral therapy (HAART) was examined among participants in the Women's Interagency HIV Study who were followed from HAART initiation to 2001. Propensity score selection was used to match 77 hormonal contraceptive users with 77 nonusers on age, race, and pre-HAART CD4-positive T-lymphocyte (CD4+ cell) count and viral load. The authors compared hormonal contraceptive users and nonusers with regard to the CD4+ cell count and viral load responses to HAART upon initiation. Proportional hazards analyses were used to assess the effect of hormonal contraceptive use on times to increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 and achievement of an undetectable viral load. There were no statistically significant differences in CD4+ cell counts and log viral load responses by hormone use after HAART initiation, except in log viral load at the third visit after initiation (p = 0.047). Time-dependent hormonal contraceptive use was not a statistically significant predictor of achieving increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 or an undetectable viral load (p = 0.517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART.",
keywords = "Antiretroviral therapy, highly active, Contraceptives, oral, hormonal, HIV, Hormones, Levonorgestrel, Medroxyprogesterone 17-acetate",
author = "Chu, {Jaclyn H.} and Gange, {Stephen J.} and Kathryn Anastos and Howard Minkoff and Helen Cejtin and Melanie Bacon and Alexandra Levine and Greenblatt, {Ruth M.}",
year = "2005",
month = "5",
day = "1",
doi = "10.1093/aje/kwi116",
language = "English (US)",
volume = "161",
pages = "881--890",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy

AU - Chu, Jaclyn H.

AU - Gange, Stephen J.

AU - Anastos, Kathryn

AU - Minkoff, Howard

AU - Cejtin, Helen

AU - Bacon, Melanie

AU - Levine, Alexandra

AU - Greenblatt, Ruth M.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - The role of hormonal contraceptive use in the effectiveness of highly active antiretroviral therapy (HAART) was examined among participants in the Women's Interagency HIV Study who were followed from HAART initiation to 2001. Propensity score selection was used to match 77 hormonal contraceptive users with 77 nonusers on age, race, and pre-HAART CD4-positive T-lymphocyte (CD4+ cell) count and viral load. The authors compared hormonal contraceptive users and nonusers with regard to the CD4+ cell count and viral load responses to HAART upon initiation. Proportional hazards analyses were used to assess the effect of hormonal contraceptive use on times to increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 and achievement of an undetectable viral load. There were no statistically significant differences in CD4+ cell counts and log viral load responses by hormone use after HAART initiation, except in log viral load at the third visit after initiation (p = 0.047). Time-dependent hormonal contraceptive use was not a statistically significant predictor of achieving increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 or an undetectable viral load (p = 0.517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART.

AB - The role of hormonal contraceptive use in the effectiveness of highly active antiretroviral therapy (HAART) was examined among participants in the Women's Interagency HIV Study who were followed from HAART initiation to 2001. Propensity score selection was used to match 77 hormonal contraceptive users with 77 nonusers on age, race, and pre-HAART CD4-positive T-lymphocyte (CD4+ cell) count and viral load. The authors compared hormonal contraceptive users and nonusers with regard to the CD4+ cell count and viral load responses to HAART upon initiation. Proportional hazards analyses were used to assess the effect of hormonal contraceptive use on times to increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 and achievement of an undetectable viral load. There were no statistically significant differences in CD4+ cell counts and log viral load responses by hormone use after HAART initiation, except in log viral load at the third visit after initiation (p = 0.047). Time-dependent hormonal contraceptive use was not a statistically significant predictor of achieving increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 or an undetectable viral load (p = 0.517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART.

KW - Antiretroviral therapy, highly active

KW - Contraceptives, oral, hormonal

KW - HIV

KW - Hormones

KW - Levonorgestrel

KW - Medroxyprogesterone 17-acetate

UR - http://www.scopus.com/inward/record.url?scp=17744376164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744376164&partnerID=8YFLogxK

U2 - 10.1093/aje/kwi116

DO - 10.1093/aje/kwi116

M3 - Article

C2 - 15840621

AN - SCOPUS:17744376164

VL - 161

SP - 881

EP - 890

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 9

ER -